Navigation Links
MEDPOR Orbital Rim Implant (IMORI)

ProductsMEDPOR Orbital Rim Implant (IMORI)
Company Porex Surgical Products Group
Item MEDPOR Orbital Rim Implant (IMORI)
Features The IMORI is smaller and more delicate than previous alloplastic implants designed for this indication and requires a smaller area of subperiosteal dissection. The implant is designed to wrap over the inferior orbital rim and extends superiorly and inferiorly medial to the inferior orbital nerve. The implant can be trimmed at the time of surgery to fit the needs of the individual patient.
Description The new Inferior Medial Orbital Rim Implant (IMORI) provides surgeons with an excellent alternative for patients with a deficient or recessed "tear trough" area often characterized as a look of fatigue or circles under the eyes.
Info Porex Surgical Products Group
Customer Service: (800) 521-7321
Web site: http://www.porexsurgical.com

Related medicine products :

1. MEDPOR Orbital Rim Onlay Implants
2. MEDPOR Orbital Rims
3. MEDPOR Inferior Orbital Rims
4. MEDPOR Midface Rim
5. MEDPOR Superior Lateral Orbital Rim
6. MEDPOR Complete Orbit Complex
7. MEDPOR 2/3 Orbit Complex
8. MEDPOR Miniplate Channel Implant
9. MEDPOR Barrier Miniplate Channel Implant
10. MEDPOR Enophthalmos Shapes
11. MEDPOR Sphere Inserter
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications....
Auto Plate Washer: 96-well washing. The ELx405 Auto Washer is the most precise and reliable washer available. Many unique features lower background absorbance values and increase the signal-to-noise ...
... This new microplate reader for fluorescence ... an emphasis on superior performance in ... sensitive glow luminescence measurements. Synergy HT ... mm top, 5 mm bottom probe, ...
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
Medicine Products:
(Date:8/29/2014)... 2014 Pursuing its deepest desires to ... unveil a stunning new design that promises to redefine ... highly notable surrogacy platform has witnessed a 42 percent ... visitors a month, the FindSurrogateMother.com community is formed by ... common goal — the precious gift of life. , ...
(Date:8/29/2014)... of clinical trials based on administering antidepressants for ... that more trials are needed to determine whether ... on a regular basis., Dr. Ian Gilron, a ... the Department of Anesthesiology, and his team of ... the use of antidepressants for pain relief post-surgery ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 A ... hearing wellness solutions, is on its way to the ... the San Diego Convention Center to exhibit and demonstrate ... work in high-noise industrial environments. Etymotic’s safety earphones and ... wearable technology devices at the show. , The ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... “The Safety Chick” who profiled a handful of ... Earphones from Etymotic Research. This year, many schools ... and Etymotic, an innovator of hearing wellness solutions, ... Their ETY•Kids Safe-Listening Earphones, offered in yellow, pink ...
(Date:8/29/2014)... The microbiology testing sector is one of ... it is also the hugest challenge facing suppliers during ... spread of AIDS – still the world’s key health ... of opportunistic infections (OIs); bioterrorism threat; advancements in technologies ... medicines. Although for certain infections the etiology remains a ...
Breaking Medicine News(10 mins):Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Antidepressants show potential for postoperative pain 2Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3
... ... coverage of anti-aging supplements has created a brand new market for health supplements, customers ... has garnered special attention, HGH Supplements like Sytropin. , ... (PRWEB) February 23, 2010 -- Increased positive coverage ...
... ... for training coders, admins, techs, and nurses through online continuing education. , ... Fort Lauderdale, FL (PRWEB) February ... has developed online continuing education programs for nurses , human resources administrators, and ...
... , ... ... ... ...
... ... ... ... ...
... February 23, 2010 Researchers from The George Washington University, ... that asthma, a largely manageable and chronic disease, is on ... magnitude of the asthma crisis, the surging cost of treatment, ... are uninsured. A new report from GW, Changing pO2licy: ...
... condition that leads to severe physical and mental deterioration, psychiatric ... to slow down or stop it. HD sufferers are ... until late in life. In a new study published ... Fabiola Ribeiro of Robarts Research Institute at The University of ...
Cached Medicine News:Health News:Sytropin HGH Shows Promising Anti-Aging Results 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 2Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 4Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 2Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 3Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 4Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 6Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 7Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 8Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 9Health News:Startling new childhood asthma data 2Health News:Startling new childhood asthma data 3Health News:Startling new childhood asthma data 4Health News:Protecting the brain from of a deadly genetic disease 2
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... release its financial results for the fiscal 2014 fourth ... trading ends on Tuesday, September 9, 2014. ... p.m. U.S. EDT on Tuesday, September 9, 2014 (Wednesday, ... Company,s financial results, commercial partnerships, and future outlook.  The ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2